Preventative and corrective/remedial maintenance repair service agreement for facscanto II flow cytometer and high throughput sampler

Ended Awarded Last action

Contract number
75F40118F10322
Awardee
Awarding agency
Obligated
$62,449

Award facts

Opportunity
Contract value 100% obligated
$62,449.13 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Jefferson, AR 72079, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00006 -$19,039
Exercise an Option P00005 $15,298
Other Administrative Action P00004 · Incorporate hhsar clause 352.232-71 electronic submission of payment requests (FEB 2022); and incorporate FDA article FDA electronic invoicing and payment… $0
Exercise an Option P00003 $15,298
Exercise an Option P00002 $15,298
Exercise an Option P00001 $15,298
Original award $20,298

About this award

The U.S. Food and Drug Administration awarded a $62,449.13 delivery order contract to Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, for preventative and corrective/remedial maintenance repair services for a FACSCanto II Flow Cytometer and high-throughput sampler. This firm fixed-price delivery order was awarded on August 23, 2018, with an ultimate completion date of September 13, 2023, with performance to occur in Jefferson, Arkansas. The contract was awarded on a full and open competition basis with no small business set-aside designation, reflecting BD's established competitive position as a leading provider of flow cytometry systems and related maintenance services to federal agencies.

BD Biosciences specializes in sophisticated scientific instruments and diagnostic products, with extensive federal contract experience across the Department of Veterans Affairs, National Institutes of Health, Centers for Disease Control and Prevention, and other government healthcare and research institutions. This delivery order falls under the Scientific Equipment and Services GSA Schedule (FSS-66) and represents the type of ongoing maintenance support that enables FDA research and diagnostic operations to sustain critical laboratory infrastructure for biomedical research and testing applications.

Quick answers

Who was awarded contract 75F40118F10322?

75F40118F10322 was awarded to Becton, Dickinson And Company by Food and Drug Administration (Department of Health and Human Services) on August 23, 2018.

How much is contract 75F40118F10322 worth?

The government has obligated $62,449 on 75F40118F10322.

Is contract 75F40118F10322 an order under another contract?

Yes. 75F40118F10322 is a delivery order under GS07F195DA, a federal supply schedule, on Scientific Equipment and Services (FSS-66).

Was contract 75F40118F10322 competed?

The extent of competition for 75F40118F10322 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award